Sponsor pipeline

Apollo Therapeutics Ltd clinical trial pipeline

Get alerts when Apollo Therapeutics Ltd's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Early Phase 1
1
Phase 1
1
Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07599813 A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic… Atopic Dermatitis Recruiting 2026-08-28
NCT06846554 A Trial of "APL-9796'' in Adults With Pulmonary Hypertension Pulmonary Arterial Hypertension Recruiting 2026-05-11
Phase 1
NCT06372717 A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS Acute Myeloid Leukemia Refractory Recruiting 2026-06-01
Early Phase 1
NCT07399132 A Study of APL-10456-Vaccine Rhinovirus Active, Not Recruiting 2026-05-27

Disease areas by active trials

Acute Myeloid Leukemia (AML) (1) · Atopic Dermatitis (1) · Hypertension (1) · Leukemia (1) · Myelodysplastic Syndromes (MDS) (1)

Get alerts when Apollo Therapeutics Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free